Evidence map›Paper›PMID 29134129›Full record

ArticleFuture science OA2017

Comparison of Clinical & Laboratory Standards Institute standards in antimicrobial susceptibility among the carbapenemase producing

Fidelis Enyinnaya, Patricia Cruz, Mark P Buttner, Chad Cross, David R Woodard

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future science OA, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fidelis EnyinnayaDepartment of Environmental & Occupational Health, School of Community Health Sciences, University of Nevada, Las Vegas, 4505 S. Maryland Parkway, Box 453064, Las Vegas, NV 89154-3064, USA.
Patricia CruzDepartment of Environmental & Occupational Health, School of Community Health Sciences, University of Nevada, Las Vegas, 4505 S. Maryland Parkway, Box 453064, Las Vegas, NV 89154-3064, USA.
Mark P ButtnerDepartment of Environmental & Occupational Health, School of Community Health Sciences, University of Nevada, Las Vegas, 4505 S. Maryland Parkway, Box 453064, Las Vegas, NV 89154-3064, USA.
Chad CrossDepartment of Environmental & Occupational Health, School of Community Health Sciences, University of Nevada, Las Vegas, 4505 S. Maryland Parkway, Box 453064, Las Vegas, NV 89154-3064, USA.
David R WoodardDepartment of Environmental & Occupational Health, School of Community Health Sciences, University of Nevada, Las Vegas, 4505 S. Maryland Parkway, Box 453064, Las Vegas, NV 89154-3064, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimCarbapenems are antibiotics reserved for treatment of severe infections. Carbapenem antimicrobial susceptibility testing profiles were determined in a population of MATERIALS &

methodsIsolates were examined using an automated antimicrobial susceptibility testing method, and real time polymerase chain reaction to detect the resistance (

resultsThe prevalence of

conclusionThis study shows that the current Clinical and Laboratory Standards Institute criteria may not offer additional benefits in the fight against carbapenem-resistant

Indexed as

antibioticsantimicrobial stewardshipcarbapenemcarbapenem resistanceClinical and Laboratory Standards InstituteKlebsiella pneumoniae

Identifiers

PMID29134129
PMCPMC5674275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.